Bibliographic Info
GuidelineWHO consolidated guidelines on tuberculosis: Module 4: Treatment - Drug-resistant tuberculosis treatment
Year of Publication2020
Issuing InstitutionWorld Health Organization
Recommendation
Status
Maintained
Recommended against
Conditional
Certainty of evidence
Very low
In patients with confirmed rifampicin-susceptible, isoniazid-resistant tuberculosis, it is not recommended to add streptomycin or other injectable agents to the treatment regimen
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
WHO guidelines on tuberculosis infection prevention and control: 2019 update
Year2019
InstitutionWHO
Guideline
WHO consolidated guidelines on tuberculosis: module 5: management of tuberculosis in children and adolescents.
Year2022
InstitutionWHO